老年人的饮食omega-3摄入量和认知功能
Bingdian Wang1,2, Deqin Li2, Cuicui Peng2
1School of Nursing, Anhui Medical University, Hefei, China.
International journal of psychiatry in medicine
|September 15, 2024
概括
摄入较高的omega-3多不和脂肪酸 (PUFA) 与老年人更好的认知功能有关. 这表明omega-3可能有助于预防与年龄相关的认知衰退.
科学领域:
- 营养科学 营养科学
- 神经科学是一个神经科学.
- 老年学是一门学科.
背景情况:
- 饮食习惯在老年人群中显著影响认知健康.
- 欧米茄-3多不和脂肪酸 (PUFA) 是重要的营养素,但它们在老年人的认知功能中的特殊作用需要进一步研究.
研究的目的:
- 调查Omega-3PUFA消费与老年人认知功能之间的关联.
- 为了确定是否增加omega-3摄入量与60岁及以上个体的认知表现改善有关.
主要方法:
- 来自国家健康和营养检查调查 (NHANES) 的2430名60岁以上美国成年人的横截面数据的分析.
- 使用线性回归模型和平滑曲线分析来评估omega-3摄入量与认知结果之间的关联.
- 进行了子组分析,以验证研究结果并确定影响因素.
主要成果:
- 在三项认知测试中的omega-3摄入量和分数之间观察到显著的正相关性:CERAD单词学习,动物流利性和数字符号替换.
- 完全调整后的模型显示了统计学上显著的关联 (P < 0.0001用于单词学习,P = 0.001用于动物流利性,P = 0.0045用于数字符号).
结论:
- 增加omega-3摄入量与老年人认知功能的增强独立相关.
- 摄入omega-3PUFAs可能有助于缓解与年龄相关的认知衰退.
- 建议进行进一步的前性研究,以确定直接的因果关系.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
相关概念视频
Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108
Environmental Influences on Intelligence
234
Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
234
Information Processing Approach
32
The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
32
Role of Neurotransmitters in Memory
482
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
482
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
